Short Term Effect of Post Surgical Treatment of Mirror Therapy of Phantom Limb Pain

NCT ID: NCT01913899

Last Updated: 2013-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is the measurement of the short term effect of post surgical mirror therapy concerning pain intensity and frequency of patients with upper or lower amputation in comparison to standard occupational or physical therapy. The hypothesis is that patients in the intervention group (mirror therapy) suffer significantly less from phantom limb pain and pain attacks within a follow-up period of 4-8 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim:

* Measurement of the short term effect of post surgical/ post-operative mirror therapy concerning pain intensity of patients with upper or lower amputation in comparison to standard occupational/ physical therapy
* Hypothesis: patients in the intervention group (mirror therapy) suffer from significant less phantom limb pain and a lower pain frequency within a follow-up period of 4-8 weeks

Methods:

* Design: multicenter, prospective, randomized controlled trial
* Participants: 70, 35 per intervention and con-trol group
* Intervention group: treatment sessions of 60 minutes with mirror therapy over a period of 14 days starting directly post surgical (24-48 hours)
* Control group: receive treatment session of 60 minutes with the same treatment frequency over a period of 14 days
* Measurement tools:

Primary objectives

* pain intensity (11 point NRS, phantom limb in-tensity)
* pain frequency (amount of pain attacks) Secondary objectives
* diary
* daily assessment of mirror and physical thera-py sessions
* analysis:
* in significant differences between the groups a covariance analysis will be performed
* comparison of medians

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phantom Limb Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mirror therapy

60 minutes of mirror therapy each day over a period of 14 days starting directly post surgically (24-48 hours after surgery)

Group Type EXPERIMENTAL

Occupational/ physical therapy

Intervention Type OTHER

Mirror therapy

Intervention Type OTHER

\- Intervention group: treatment sessions of 60 minutes with mirror therapy over a period of 14 days starting directly post surgical (24-48 hours)

Occupational/ physical therapy

60 minutes of occupational/ physical therapy each day over a period of 14 days starting 24-48 hours post surgically

Group Type ACTIVE_COMPARATOR

Occupational/ physical therapy

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Occupational/ physical therapy

Intervention Type OTHER

Mirror therapy

\- Intervention group: treatment sessions of 60 minutes with mirror therapy over a period of 14 days starting directly post surgical (24-48 hours)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* major amputation of lower and upper body
* phantom pain, or pain attacks in combination with a treatment wish
* age of 18 years
* signed informed consent
* linguistic and cognitive comprehension

Exclusion Criteria

* bilateral amputation
* major neurologic comorbidities (stroke, Parkinson disease)
* morbidities of the contralateral side with functional limitations
* experience with long term standardised mirror therapy
* internal comorbidities (pAVK)
* psychological comorbidities
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Deutsche Gesetzliche Unfallversicherung (DGUV)

UNKNOWN

Sponsor Role collaborator

Ruhr University of Bochum

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christoph Maier, Prof. Dr.

Prof. Dr. Christoph Maier

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christoph Maier, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Ruhr University Bochum

Andreas Schwarzer, Dr. Dr.

Role: PRINCIPAL_INVESTIGATOR

Ruhr University of Bochum

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH

Bochum, North Rhine-Westphalia, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Andreas Schwarzer, Dr. Dr.

Role: CONTACT

0049-234-3023430

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Andreas Schwarzer, Dr. Dr.

Role: primary

0049-234-3023430

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4318-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.